Prognostic utility of admission cell-free DNA levels in patients with chronic obstructive pulmonary disease exacerbations

BACKGROUND: Chronic obstructive pulmonary disease exacerbations (COPDEs) are associated with increased morbidity and mortality. Cell-free DNA (cfDNA) is a novel biomarker associated with clinical outcomes in several disease states but has not been studied in COPD. The objectives of this study were t...

Descripción completa

Detalles Bibliográficos
Autores principales: Avriel, Avital, Rozenberg, Dmitry, Raviv, Yael, Heimer, Dov, Bar-Shai, Amir, Gavish, Rachel, Sheynin, Jony, Douvdevani, Amos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5158140/
https://www.ncbi.nlm.nih.gov/pubmed/28003743
http://dx.doi.org/10.2147/COPD.S113256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5158140/
https://www.ncbi.nlm.nih.gov/pubmed/28003743
http://dx.doi.org/10.2147/COPD.S113256

Ejemplares similares